Letter to the editor: The addition of C-reactive protein and von Willebrand factor to Model for End-Stage Liver Disease-Sodium

被引:1
|
作者
Luo, Meng-Si [1 ]
Huang, Guan-Jiang [2 ]
机构
[1] Guangzhou Univ Chinese Med, Zhongshan Hosp Tradit Chinese Med, Dept Anesthesiol, Zhongshan, Peoples R China
[2] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Otorhinolaryngol, 88 Jiefang Rd, Hangzhou 310009, Peoples R China
关键词
D O I
10.1002/hep.32252
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:763 / 764
页数:2
相关论文
共 50 条
  • [21] Model for end-stage liver disease-sodium predicts prognosis in patients with chronic severe hepatitis B
    Cai Chang-Jie
    Chen Hu-An
    Lu Min-Qiang
    Chen Gui-Hua
    CHINESE MEDICAL JOURNAL, 2008, 121 (20) : 2065 - 2069
  • [22] Model for end-stage liver disease-sodium predicts prognosis in patients with chronic severe hepatitis B
    CAI ChangjieCHEN HuanLU Minqiang and CHEN Guihua Department of Liver TransplantationThird Affiliated Hospital of Sun Yatsen UniversityGuangzhouGuangdong China
    中华医学杂志(英文版), 2008, (20) : 2065 - 2069
  • [23] Model For End-Stage Liver Disease-Sodium (MELD-Na) Predicts Survival in Patients with Hepatocellular Carcinoma
    Jafarimehr, Elnaz
    Tombazzi, Claudio
    Weir, Alva
    Waters, Bradford
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2012, 107 : S176 - S176
  • [24] Effects of Allocating Livers for Transplantation Based on Model for End-Stage Liver Disease-Sodium Scores on Patient Outcomes
    Nagai, Shunji
    Chau, Lucy C.
    Schilke, Randolph E.
    Safwan, Mohamed
    Rizzari, Michael
    Collins, Kelly
    Yoshida, Atsushi
    Abouljoud, Marwan S.
    Moonka, Dilip
    GASTROENTEROLOGY, 2018, 155 (05) : 1451 - +
  • [25] The in vitro effects of sodium salicylate on von Willebrand factor and C-reactive protein production by endothelial cells
    Shahidi, Minoo
    Barati, Mahmood
    Hayat, Parisa
    Tavasoli, Behnaz
    Bakhshayesh, Masoomeh
    INFLAMMOPHARMACOLOGY, 2014, 22 (06) : 367 - 372
  • [26] The in vitro effects of sodium salicylate on von Willebrand factor and C-reactive protein production by endothelial cells
    Minoo Shahidi
    Mahmood Barati
    Parisa Hayat
    Behnaz Tavasoli
    Masoomeh Bakhshayesh
    Inflammopharmacology, 2014, 22 : 367 - 372
  • [27] Von Willebrand Factor Facilitates Model of End-Stage Liver Disease-Independent Risk Stratification on the Waiting List for Liver Transplantation
    Pereyra, David
    Gyoeri, Georg
    Rumpf, Benedikt
    Koeditz, Christoph
    Ortmayr, Gregor
    Reiberger, Thomas
    Berlakovich, Gabriela A.
    Starlinger, Patrick
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2019, 229 (04) : S288 - S288
  • [28] The von Willebrand Factor Facilitates Model for End-Stage Liver Disease-Independent Risk Stratification on the Waiting List for Liver Transplantation
    Gyoeri, Georg P.
    Pereyra, David
    Rumpf, Benedikt
    Hackl, Hubert
    Koeditz, Christoph
    Ortmayr, Gregor
    Reiberger, Thomas
    Trauner, Michael
    Berlakovich, Gabriela A.
    Starlinger, Patrick
    HEPATOLOGY, 2020, 72 (02) : 584 - 594
  • [29] C-reactive protein as a cardiovascular risk factor and its therapeutic implications in end-stage renal disease patients
    Park, JS
    Kim, SB
    NEPHROLOGY, 2003, 8 : S40 - S44
  • [30] The predictive value of C-reactive protein in end-stage renal disease: Is it clinically significant?
    van der Sande, Frank M.
    Kooman, Jeroen P.
    Leunissen, Karel M. L.
    BLOOD PURIFICATION, 2006, 24 (04) : 335 - 341